News
Hemogenyx Pharmaceuticals Successfully Completes the Site Initiation Visit of the First Clinical Site for Phase I Clinical Trial of HG-CT-1 LONDON, UNITED KINGDOM / ACCESSWIRE / December 9, 2024 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback